Using the microbiome to treat disease

BiomeBank is a clinical stage biotechnology company developing microbial therapies

What is BiomeBank?

BiomeBank is a clinical stage biotechnology company developing a Pipeline of live biotherapeutic products to treat disease. BiomeBank's mission is to treat and prevent disease by replenishing gut microbial ecology. We currently provide BiomeBoost, a drug product which contains a broad-spectrum of microbes, for treatment of recurrent Clostridioides difficile.

Platform & Pipeline

BiomeBank has a world leading team of translational microbiome experts. Our Platform uses a unique combination of machine learning and microbiology to identify bacterial strains which influence disease. We use this to discover and develop microbial therapies.

Plan.png

Contact us

Hospital or Patient? Don't hesitate to contact us using the form below or call us on 08 8152 9370.